LSPCX
Price
$5.71
Change
+$0.03 (+0.53%)
Updated
Jun 2 closing price
Net Assets
70.85M
MBXCX
Price
$43.66
Change
-$0.14 (-0.32%)
Updated
Jun 2 closing price
Net Assets
10.13B
Interact to see
Advertisement

LSPCX vs MBXCX

Header iconLSPCX vs MBXCX Comparison
Open Charts LSPCX vs MBXCXBanner chart's image
LSPCX vs MBXCX Comparison Chart in %
View a ticker or compare two or three
VS
LSPCX vs. MBXCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSPCX is a Buy and MBXCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXCX has more cash in the bank: 10.1B vs. LSPCX (70.9M). LSPCX pays higher dividends than MBXCX: LSPCX (7.33) vs MBXCX (0.00). LSPCX was incepted earlier than MBXCX: LSPCX (12 years) vs MBXCX (10 years). LSPCX (4.24) is less costly to investors than MBXCX (3.00). LSPCX is a more actively managed with annual turnover of: 66.00 vs. MBXCX (19.00). LSPCX (2500) and MBXCX (2500) have matching initial minimum investment requirements. MBXCX annual gain was more profitable for investors over the last year : 20.16 vs. LSPCX (12.43). MBXCX return over 5 years is better than : 30.60 vs. LSPCX (9.89).
LSPCXMBXCXLSPCX / MBXCX
Total Expense Ratio4.193.00140%
Annual Report Gross Expense Ratio4.243.00141%
Fund Existence12 years10 years-
Gain YTD6.04212.97447%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets70.9M10.1B1%
Annual Yield % from dividends7.330.00-
Returns for 1 year12.4320.1662%
Returns for 3 years31.9233.9494%
Returns for 5 years9.8930.6032%
Returns for 10 years44.9786.0752%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRWCX37.91N/A
N/A
T. Rowe Price Capital Appreciation
MSFBX26.29N/A
N/A
Morgan Stanley Inst Global Franchise A
BRTNX79.58N/A
N/A
Bretton Fund
TRHBX30.31N/A
N/A
Nuveen Small Cap Blend Idx I
AIQQX21.19N/A
N/A
Aristotle Value Equity I-2